• The Future of Psychedelics and Biotech With Tim Schlidt of Palo Santo

  • Sep 22 2021
  • Length: 1 hr and 2 mins
  • Podcast

The Future of Psychedelics and Biotech With Tim Schlidt of Palo Santo

  • Summary

  • This episode we speak with Tim Schlidt, the co-founder of a psychedelic therapeutics investment fund called Palo Santo.

    We discuss the future of psychedelics from a biotech perspective. Which substances that are the most likely to receive FDA approval in the near future, and how the biotech sector is getting involved. From MDMA to psilocybin, and even some less common substances you may not have heard of.

    Episode Page:

    www.moveconsciousness.com/palosanto

    Palo Santo Website:

    palosanto.vc/

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The Future of Psychedelics and Biotech With Tim Schlidt of Palo Santo

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.